About Dawaa Dost
Dawaa Dost is a company based in Jaipur (India) founded in 2018 by Anirudh Batwara, Amit Choudhary, and Yash Harlalka. Dawaa Dost has raised $16.18 million across 8 funding rounds from investors including Kredent InfoEdge, Grameen Capital and Indcap Advisors. The company has 27 employees as of April 09, 2024. Dawaa Dost offers products and services including Generic Medicines, Health Products, Derma Products, and Diabetes Care. Dawaa Dost operates in a competitive market with competitors including Tata 1mg, Netmeds, Truemeds, PharmEasy and MedPlus, among others.
- Headquarter Jaipur, India
- Employees 27 as on 09 Apr, 2024
- Founders Anirudh Batwara, Amit Choudhary, Yash Harlalka
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dawaa Dost Retail Private Limited
- Date of Incorporation 16 Nov, 2021
- Jurisdiction Kolkata, West Bengal, India
-
Annual Revenue
$538.81 K (USD)1138.87as on Mar 31, 2023
-
Net Profit
-$125.01 K (USD)-298.07as on Mar 31, 2023
-
EBITDA
-$118.63 K (USD)-212.43as on Mar 31, 2023
-
Total Equity Funding
$16.18 M (USD)
in 8 rounds
-
Latest Funding Round
$2.87 M (USD), Seed
Mar 10, 2025
-
Investors
Kredent InfoEdge
& 108 more
-
Employee Count
27
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dawaa Dost
Dawaa Dost offers a comprehensive portfolio of products and services, including Generic Medicines, Health Products, Derma Products, and Diabetes Care.
Affordable drugs for conditions like diabetes and pain relief
Items for skin, hair, and wellness needs
Solutions for skin health and maintenance
Medicines and aids for diabetes management
Funding Insights of Dawaa Dost
Dawaa Dost has successfully raised a total of $16.18M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $2.87 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Seed — $2.9M
-
First Round
First Round
(18 Oct 2019)
- Investors Count 109
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Seed - Dawaa Dost | Valuation | Sandeep Kapadia | |
| Jan, 2024 | Amount | Seed - Dawaa Dost | Valuation | Rba Finance and Investment | |
| Jan, 2023 | Amount | Seed - Dawaa Dost | Valuation |
investors |
Investors in Dawaa Dost
Dawaa Dost has secured backing from 109 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Kredent InfoEdge, Grameen Capital and Indcap Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel network focused on India, Singapore, and U.S based companies
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on pre-seed and seed stage investments in financial services, real estate, and technology sectors
|
Founded Year | Domain | Location | |
|
Early-stage companies are invested in by Better Capital.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dawaa Dost
Financial Statements - Dawaa Dost
Dawaa Dost Comparisons
Competitors of Dawaa Dost
Dawaa Dost operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tata 1mg, Netmeds, Truemeds, PharmEasy and MedPlus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of an online pharmacy with doctor listing and teleconsultation services
|
|
| domain | founded_year | HQ Location |
Provider of an online store for medicines and healthcare products
|
|
| domain | founded_year | HQ Location |
Provider of an online pharmacy and telehealth platform
|
|
| domain | founded_year | HQ Location |
Provider of an online pharmacy and healthcare platforms
|
|
| domain | founded_year | HQ Location |
Medicines and health products are retailed through pharmacy outlets.
|
|
| domain | founded_year | HQ Location |
An online marketplace for healthcare products is operated.
|
Frequently Asked Questions about Dawaa Dost
Dawaa Dost was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Dawaa Dost is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
Amit Choudhary is the current CEO of Dawaa Dost. They have also founded this company.
Dawaa Dost is a funded company, having raised a total of $16.18M across 8 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on Oct 18, 2019.
As of Apr 09, 2024, the latest employee count at Dawaa Dost is 27.
Annual revenue of Dawaa Dost is $538.81K as on Mar 31, 2023.
Founded in 2018 in Jaipur, India, Dawaa Dost operates within the online pharmacy sector. Generic medicines, personal care items, and health products are supplied via its digital platform, with home delivery provided to customers. Prescriptions can be uploaded to enable orders, supporting access to healthcare essentials across the region. The model emphasizes direct-to-consumer distribution without physical stores.
Dawaa Dost's top competitors include Tata 1mg, SastaSundar and PharmEasy.
Dawaa Dost offers Generic Medicines, Health Products, Derma Products, and Diabetes Care.
Dawaa Dost has 109 investors. Key investors include Kredent InfoEdge, Grameen Capital, Indcap Advisors, QED Innovation, and Jhaveri Group.
The valuation of Dawaa Dost is $52.75M as of Mar 2025.